1. Corinaldesi, C.; Barone, G.; Marcellini, F.; Anno, A. D.; Danovaro, R. Marine Microbial-Derived Molecules and Their Potential Use in Cosmeceutical and Cosmetic Products. 2017, 1–21, doi:10.3390/md15040118.
2. UNCSGN Eleventh United Nations Conference on the Standardization of Geographical Names; 2016; Vol. 388;.
3. Cuellar-Bermudez, S. P.; Aguilar-Hernandez, I.; Cardenas-Chavez, D. L.; OrnelasSoto, N.; Romero-Ogawa, M. A.; Parra-Saldivar, R. Extraction and purification of high-value metabolites from microalgae: Essential lipids, astaxanthin and phycobiliproteins. Microb. Biotechnol. 2015, 8, 190–209, doi:10.1111/1751- 7915.12167.
4. Hayes, M. Marine bioactive compounds: Sources, characterization and applications; 2012; Vol. 9781461412; ISBN 9781461412472.
5. Norzagaray-Valenzuela, C. D.; Valdez-Ortiz, A.; Shelton, L. M.; Jiménez-Edeza, M.; Rivera-López, J.; Valdez-Flores, M. A.; Germán-Báez, L. J. Residual biomasses and protein hydrolysates of three green microalgae species exhibit antioxidant and antiaging activity. J. Appl. Phycol. 2017, 29, 189–198, doi:10.1007/s10811-016-0938-9.
6. Borowitzka, M. a. Microalgae for aquaculture: Opportunities and constraints. J. Appl. Phycol. 1997, 9, 393–401, doi:10.1023/A:1007921728300.
7. Mourelle, M.; Gómez, C.; Legido, J. The Potential Use of Marine Microalgae and Cyanobacteria in Cosmetics and Thalassotherapy. Cosmetics 2017, 4, 46, doi:10.3390/cosmetics4040046.
8. Prasetiya, F. S.; Safitri, I.; Widowati, I.; Cognie, B.; Decottignies, P.; Gastineau, R.; Morançais, M.; Windarto, E.; Tremblay, R.; Mouget, J.-L. Does allelopathy affect coculturing Haslea ostrearia with other microalgae relevant to aquaculture? J. Appl. Phycol. 2016, 28, 2241–2254, doi:10.1007/s10811-015-0779-y.
9. Gastineau, R.; Turcotte, F.; Pouvreau, J.-B.; Morançais, M.; Fleurence, J.; Windarto, E.; Prasetiya, F. S.; Arsad, S.; Jaouen, P.; Babin, M.; Coiffard, L.; Couteau, C.; Bardeau, J.-F.; Jacquette, B.; Leignel, V.; Hardivillier, Y.; Marcotte, I.; Bourgougnon, N.; Tremblay, R.; Deschênes, J.-S.; Badawy, H.; Pasetto, P.; Davidovich, N.; Hansen, G.; Dittmer, J.; Mouget, J.-L. Marennine, promising blue pigments from a widespread Haslea diatom species complex. Mar. Drugs 2014, 12, 3161–3189, doi:10.3390/md12063161.
10. Gastineau, R.; Pouvreau, J. B.; Hellio, C.; Morançais, M.; Fleurence, J.; Gaudin, P.; Bourgougnon, N.; Mouget, J. L. Biological activities of purified marennine, the blue pigment responsible for the greening of oysters. J. Agric. Food Chem. 2012, 60, 3599– 3605, doi:10.1021/jf205004x.
11. Prasetiya, F. S.; Sunarto, S.; Bachtiar, E.; Agung, M. U. K.; Nathanael, B.; Pambudi, A. C.; Lestari, A. D.; Astuty, S.; Mouget, J. Effect of the blue pigment produced by the tropical diatom Haslea nusantara on marine organisms from different trophic levels and its bioactivity. Aquac. Reports 2020, 17, 100389, doi:10.1016/j.aqrep.2020.100389.
12. Prasetiya, F. S.; Ramdhani, D. S.; Mulyani, Y.; Mochamad, U.; Agung, K.; Arsad, S.; Mouget, J. Antioxidant activities of culture supernatant Haslea ostrearia adapted in Indonesia. AACL Bioflux 2021, 14, 111–119.
13. de Morais, M. G.; da Silva Vaz, B.; Etiele Greque, de M.; Vieira Costa, J. A. Review Article Biologically Active Metabolites Synthesized by Microalgae. Biomed Res. Int. 2015, 2015, 1–15, doi:10.1155/2015/835761.
14. Silva, T.; S. Salomon, P.; Hamerski, L.; Walter, J.; B. Menezes, R.; Siqueira, J. E.; Santos, A.; Santos, J. A. M.; Ferme, N.; Guimarães, T.; O. Fistarol, G.; I. Hargreaves, P.; Thompson, C.; Thompson, F.; Souza, T. M.; Siqueira, M.; Miranda, M. Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity. PeerJ 2018, 6, e5716, doi:10.7717/peerj.5716.
15. Chan, J. F. W.; Yuan, S.; Kok, K. H.; To, K. K. W.; Chu, H.; Yang, J.; Xing, F.; Liu, J.; Yip, C. C. Y.; Poon, R. W. S.; Tsoi, H. W.; Lo, S. K. F.; Chan, K. H.; Poon, V. K. M.; Chan, W. M.; Ip, J. D.; Cai, J. P.; Cheng, V. C. C.; Chen, H.; Hui, C. K. M.; Yuen, K. Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020, 395, 514–523, doi:10.1016/S0140-6736(20)30154-9.
16. Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; Xia, J.; Yu, T.; Zhang, X.; Zhang, L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020, 395, 507–513, doi:10.1016/S0140-6736(20)30211-7.
17. Zhou, P.; Yang, X. Lou; Wang, X. G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H. R.; Zhu, Y.; Li, B.; Huang, C. L.; Chen, H. D.; Chen, J.; Luo, Y.; Guo, H.; Jiang, R. Di; Liu, M. Q.; Chen, Y.; Shen, X. R.; Wang, X.; Zheng, X. S.; Zhao, K.; Chen, Q. J.; Deng, F.; Liu, L. L.; Yan, B.; Zhan, F. X.; Wang, Y. Y.; Xiao, G. F.; Shi, Z. L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273, doi:10.1038/s41586-020-2012-7.
18. Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Herrler, T.; Erichsen, S.; Schiergens, T. S.; Herrler, G.; Wu, N. H.; Nitsche, A.; Müller, M. A.; Drosten, C.; Pöhlmann, S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020, 181, 271-280.e8, doi:10.1016/j.cell.2020.02.052.
19. Wan, Y.; Shang, J.; Graham, R.; Baric, R. S.; Li, F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J. Virol. 2020, 94, 1–9, doi:10.1128/jvi.00127-20.
20. Liu, L.; Wei, Q.; Alvarez, X.; Wang, H.; Du, Y.; Zhu, H.; Jiang, H.; Zhou, J.; Lam, P.; Zhang, L.; Lackner, A.; Qin, C.; Chen, Z. Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques. J. Virol. 2011, 85, 4025–4030, doi:10.1128/jvi.02292-10.
21. de Wilde, A. H.; Snijder, E. J.; Kikkert, M.; van Hemert, M. J. Host Factors in Coronavirus Replication BT – Roles of Host Gene and Non-coding RNA Expression in Virus Infection. In; Tripp, R. A., Tompkins, S. M., Eds.; Springer International Publishing: Cham, 2018; pp. 1–42 ISBN 978-3-030-05369-7.
22. Jin, Z.; Du, X.; Xu, Y.; Deng, Y.; Liu, M.; Zhao, Y.; Zhang, B.; Li, X.; Zhang, L.; Peng, C.; Duan, Y.; Yu, J.; Wang, L.; Yang, K.; Liu, F.; Jiang, R.; Yang, X.; You, T.; Liu, X.; Yang, X.; Bai, F.; Liu, H.; Liu, X.; Guddat, L. W.; Xu, W.; Xiao, G.; Qin, C.; Shi, Z.; Jiang, H.; Rao, Z.; Yang, H. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature 2020, 2020.02.26.964882, doi:10.1101/2020.02.26.964882.
23. Hamed, I.; Özogul, F.; Özogul, Y.; Regenstein, J. M. Marine Bioactive Compounds and Their Health Benefits: A Review. Compr. Rev. Food Sci. Food Saf. 2015, 14, 446– 465, doi:10.1111/1541-4337.12136.
24. El Gamal, A. A. Biological importance of marine algae. Saudi Pharm. J. 2010, 18, 1– 25, doi:10.1016/j.jsps.2009.12.001.
25. De Morais, M. G.; Vaz, B. D. S.; De Morais, E. G.; Costa, J. A. V. Biologically Active Metabolites Synthesized by Microalgae. Biomed Res. Int. 2015, 2015, doi:10.1155/2015/835761.
26. Matsunaga, T.; Takeyama, H.; Miyashita, H.; Yokouchi, H. Marine microalgae. Adv. Biochem. Eng. Biotechnol. 2005, 96, 165–188, doi:10.1007/b135784.
27. Fu, W.; Guomundsson, Ó.; Paglia, G.; Herjólfsson, G.; Andrésson, Ó. S.; Palsson, B. O.; Brynjólfsson, S. Enhancement of carotenoid biosynthesis in the green microalga Dunaliella salina with light-emitting diodes and adaptive laboratory evolution. Appl. Microbiol. Biotechnol. 2013, 97, 2395–2403, doi:10.1007/s00253-012-4502-5.
28. Hatae, N.; Satoh, R.; Chiba, H.; Osaki, T.; Nishiyama, T.; Ishikura, M.; Abe, T.; Hibino, S.; Choshi, T.; Okada, C.; Toyota, E. N-Substituted calothrixin B derivatives inhibited the proliferation of HL-60 promyelocytic leukemia cells. Med. Chem. Res. 2014, 23, 4956–4961, doi:10.1007/s00044-014-1061-6.
29. Plaza, A.; Keffer, J. L.; Bifulco, G.; Lloyd, J. R.; Bewley, C. A. Chrysophaentins A-H, antibacterial bisdiarylbutene macrocycles that inhibit the bacterial cell division protein FtsZ. J. Am. Chem. Soc. 2010, 132, 9069–9077, doi:10.1021/ja102100h.
30. Santoyo, S.; Jaime, L.; Plaza, M.; Herrero, M.; Rodriguez-Meizoso, I.; Ibañez, E.; Reglero, G. Antiviral compounds obtained from microalgae commonly used as carotenoid sources. J. Appl. Phycol. 2012, 24, 731–741, doi:10.1007/s10811-011- 9692-1.
31. Lee, J. B.; Hayashi, K.; Hirata, M.; Kuroda, E.; Suzuki, E.; Kubo, Y.; Hayashi, T. Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from deepsea water in Toyama Bay. Biol. Pharm. Bull. 2006, 29, 2135–2139, doi:10.1248/bpb.29.2135.
32. Senhorinho, G. N. A.; Ross, G. M.; Scott, J. A. Cyanobacteria and eukaryotic microalgae as potential sources of antibiotics. Phycologia 2015, 54, 271–282, doi:10.2216/14-092.1.
33. Yuan, J. P.; Peng, J.; Yin, K.; Wang, J. H. Potential health-promoting effects of astaxanthin: A high-value carotenoid mostly from microalgae. Mol. Nutr. Food Res. 2011, 55, 150–165, doi:10.1002/mnfr.201000414.
34. Hayashi, T.; Hayashi, K.; Maeda, M.; Kojima, I. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J. Nat. Prod. 1996, 59, 83–87, doi:10.1021/np960017o.
35. Meng, X.-Y.; Zhang, H.-X.; Mezei, M.; Cui, M. Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery. Curr. Comput. Aided-Drug Des. 2012, 7, 146–157, doi:10.2174/157340911795677602.
36. Wu, C. H.; Arighi, C.; Ross, K. Protein Bioinformatics: From Protein Modifications and Networks to Proteomics. Methods Mol. Biol. 2017, 1558, 472, doi:10.1007/978-1- 4939-6783-4.
37. Ballester, P. J.; Westwood, I.; Laurieri, N.; Sim, E.; Richards, W. G. Prospective virtual screening with Ultrafast Shape Recognition : the identification of novel inhibitors of arylamine N -acetyltransferases. 2010, 335–342.
38. Merz, K. M.; Ringe, D.; Reynolds, C. H. Drug Design: Structure-and Ligand-Based Approaches; Merz, K. M., Ringe, D., Reynolds, C. H., Eds.; First Edit.; Cambridge University Press: Cambridge, 2010; ISBN 978-0-521-88723-6.
39. Ferreira, L. G.; Dos Santos, R. N.; Oliva, G.; Andricopulo, A. D. Molecular docking and structure-based drug design strategies; 2015; Vol. 20; ISBN 5516337380.
40. Allouche, A.-R. Gabedit—A Graphical User Interface for Computational Chemistry Softwares. J. Comput. Chem. 2010, 32, 174–182, doi:10.1002/jcc.
41. Ingolfsson, H. I.; Arnarez, C.; Periole, X.; Marrink, S. J. Computational ’microscopy of cellular membranes. J. Cell Sci. 2016, 129, 257–268, doi:10.1242/jcs.176040.
42. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res 2000, 28, 235–242, doi:10.1093/nar/28.1.235.
43. Nayeem, A.; Sitkoff, D.; Krystek Jr, S. A comparative study of available software for high-accuracy homology modeling: From sequence alignments to structural models. Protein Sci. 2006, 15, 808–824, doi:10.1110/ps.051892906.holdings.html.
44. Lamberti, V. E.; Fosdick, L. D.; Jessup, E. R.; Schauble, C. J. C. A Hands-On Introduction to Molecular Dynamics. J. Chem. Educ. 2002, 79, 601, doi:10.1021/ed079p601.
45. Hospital, A.; Goñi, J. R.; Orozco, M.; Gelpí, J. L. Molecular Dynamics Simulations and Flow. Adv. Appl. Bioinforma. Chem. 2015, 8, 37–47, doi:10.1021/jp9921912.
46. Hollingsworth, S. A.; Dror, R. O. Review Molecular Dynamics Simulation for All. Neuron 2018, 99, 1129–1143, doi:10.1016/j.neuron.2018.08.011.
47. Childers, M. C.; Daggett, V. Insights from molecular dynamics simulations for computational protein design. Mol. Syst. Des. Eng. 2017, 2, 9–33, doi:10.1016/B978- 0-12-809633-8.20151-9.